Literature DB >> 9030388

Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.

C Merry, F Mulcahy, M Barry, S Gibbons, D Back.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030388

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Drug interactions of HIV protease inhibitors.

Authors:  L I Malaty; J J Kuper
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 3.  Saquinavir. Clinical pharmacology and efficacy.

Authors:  S Vella; M Floridia
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

4.  Safety of midazolam for sedation of HIV-positive patients undergoing colonoscopy.

Authors:  E S Backman; V A Triant; J M Ehrenfeld; Z Lu; P Arpino; E Losina; R T Gandhi
Journal:  HIV Med       Date:  2013-01-18       Impact factor: 3.180

Review 5.  Polypharmacy in the HIV-infected older adult population.

Authors:  Lauren J Gleason; Amneris E Luque; Krupa Shah
Journal:  Clin Interv Aging       Date:  2013-06-21       Impact factor: 4.458

Review 6.  Management of acute seizures in children: A review with special consideration of care in resource-limited settings.

Authors:  Ornella Ciccone; Manoj Mathews; Gretchen L Birbeck
Journal:  Afr J Emerg Med       Date:  2017-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.